The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand

Journal of Biological Chemistry

Volumn 288, Issue 41, 2013, Pages 29923-29933

  Tse, Anfernee Kai Wing ^a   Chow, Ka Yu ^a   Cao, Hui Hui ^a   Cheng, Chi Yan ^a   Kwan, Hiu Yee ^a   Yu, Hua ^a   Zhu, Guo Yuan ^a   Wu, Yiu Cheong ^a   Fong, Wang Fun ^a   Yu, Zhi Ling ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE COMPOUNDS; CRYPTOTANSHINONE; ENHANCING EFFECT; MELANOMA CELLS; RECEPTOR EXPRESSION; SALVIA MILTIORRHIZA; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGANDS; UP-REGULATION;

GLYCOPROTEINS; LIGANDS; MACROPHAGES; PROTEINS;

CELL DEATH;

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN HOMLOGOUS PROTEIN; CRYPTOTANSHINONE; DEATH RECEPTOR 5; PLACEBO; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CONTROLLED STUDY; DR5 GENE; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TARGETING; GENE; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SALVIA MILTIORRHIZA; UPREGULATION;

APOPTOSIS; CELL DEATH; MELANOMA; REACTIVE OXYGEN SPECIES (ROS); TRAIL;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; NEOPLASMS; PHENANTHRENES; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SALVIA MILTIORRHIZA; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR CHOP; UP-REGULATION;

EID: 84885635044     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.483909     Document Type: Article

References (38)

1. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818
2. Pennarun, B., Meijer, A., de Vries, E. G., Kleibeuker, J. H., Kruyt, F., and de Jong, S. (2010) Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim. Biophys. Acta 1805, 123-140
3. Russo, M., Mupo, A., Spagnuolo, C., and Russo, G. L. (2010) Exploring death receptor pathways as selective targets in cancer therapy. Biochem. Pharmacol. 80, 674-682
4. Dimberg, L. Y., Anderson, C. K., Camidge, R., Behbakht, K., Thorburn, A., and Ford, H. L. (2013) On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32, 1341-1350
5. Mellier, G., and Pervaiz, S. (2012) The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS). Free Radic. Res. 46, 996-1003
6. Siegelin, M. D. (2012) Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis. Expert Opin. Ther. Targets 16, 801-817
7. Zhou, L., Zuo, Z., and Chow, M. S. (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45, 1345-1359
8. Zhang, Y., Jiang, P., Ye, M., Kim, S. H., Jiang, C., and Lü, J. (2012) Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int. J. Mol. Sci. 13, 13621-13666
9. Kim, J. H., Jeong, S. J., Kwon, T. R., Yun, S. M., Jung, J. H., Kim, M., Lee, H. J., Lee, M. H., Ko, S. G., Chen, C. Y., and Kim, S. H. (2011) Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells. Apoptosis 16, 696-707
10. Su, C. C. (2012) Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp. Ther. Med. 3, 555-559
11. Ye, Y., Xu, W., Zhong, W., Li, Y., and Wang, C. (2012) Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer byHPVE6 down-regulation and caspases activation. Mol. Cell. Biochem. 363, 191-202
12. Lee, W. Y., Liu, K. W., and Yeung, J. H. (2009) Reactive oxygen speciesmediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells. Cancer Lett. 285, 46-57
13. Cheng, C. Y., and Su, C. C. (2010) Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential. Mol. Med. Rep. 3, 645-650
14. Chiu, T. L., and Su CC. (2010) Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int. J. Mol. Med. 25, 231-236
15. Park, I. J., Kim, M. J., Park, O. J., Choe, W., Kang, I., Kim, S. S., and Ha, J. (2012) Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells. Apoptosis 17, 248-257
16. Tse, A. K., Wan, C. K., Shen, X. L., Yang, M., and Fong, W. F. (2005) Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochem. Pharmacol. 70, 1443-1457
17. Yang, Y., Tse, A. K., Li, P., Ma, Q., Xiang, S., Nicosia, S. V., Seto, E., Zhang, X., and Bai, W. (2011) Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Oncogene 30, 2207-2218
18. Tse, A. K., Zhu, G. Y., Wan, C. K., Shen, X. L., Yu, Z. L., and Fong, W. F. (2010) 1α,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor κB in breast cancer cells. Mol. Immunol. 47, 1728-1738
19. Abdulghani, J., and El-Deiry, W. S. (2010) TRAIL receptor signaling and therapeutics. Expert Opin. Ther. Targets 14, 1091-1108
20. Yamaguchi, H., and Wang, H. G. (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279, 45495-45502
21. Kim, Y. H., Jung, E. M., Lee, T. J., Kim, S. H., Choi, Y. H., Park, J. W., Park, J. W., Choi, K. S., and Kwon, T. K. (2008) Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic. Biol. Med. 44, 1055-1068
22. Yokouchi,M., Hiramatsu, N., Hayakawa, K., Okamura, M., Du, S., Kasai, A., Takano, Y., Shitamura, A., Shimada, T., Yao, J., and Kitamura, M. (2008) Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J. Biol. Chem. 283, 4252-4260
23. Moon, D. O., Park, S. Y., Choi, Y. H., Ahn, J. S., and Kim, G. Y. (2011) Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROSdependent ER-stress. Biochem. Pharmacol. 82, 1641-1650
24. Wu, G. S., Burns, T. F., McDonald, E. R., 3rd., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and el-Deiry, W. S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17, 141-143
25. Takimoto, R., and El-Deiry, W. S. (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19, 1735-1743
26. Seol, J. Y., Park, K. H., Hwang, C. I., Park, W. Y., Yoo, C. G., Kim, Y. W., Han, S. K., Shim, Y. S., Lee, C. T. (2003) Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Ther. 10, 540-548
27. Aydin, C., Sanlioglu, A. D., Bisgin, A., Yoldas, B., Dertsiz, L., Karacay, B., Griffith, T. S., and Sanlioglu, S. (2010) NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC Cancer 10, 584
28. Eigentler, T. K., Caroli, U. M., Radny, P., and Garbe, C. (2003) Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol. 4, 748-759
29. Julia, F., Thomas, L., and Dalle S. (2012) New therapeutical strategies in the treatment of metastatic disease. Dermatol. Ther. 25, 452-457
30. Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., and Kubin, M. Z. (1998) Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161, 2833-2840
31. Nguyen, T., Zhang, X. D., and Hersey, P. (2001) Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Clin. Cancer Res. 7, 966s-973s
32. Yaginuma, Y., and Westphal, H. (1992) Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res. 52, 4196-4199
33. Kastrinakis, W. V., Ramchurren, N., Rieger, K. M., Hess, D. T., Loda, M., Steele, G., and Summerhayes, I. C. (1995) Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 11, 647-652
34. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J. Jr., and Kohn, K. W. (1997) Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 57, 4285-4300
35. Meng, R. D., and El-Deiry, W. S. (2001) p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferongamma. Exp. Cell Res. 262, 154-169
36. Sheikh, M. S., Burns, T. F., Huang, Y., Wu, G. S., Amundson, S., Brooks, K. S., Fornace, A. J. Jr., and el-Deiry, W. S. (1998) p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58, 1593-1598
37. The State Pharmacopoeia Commission of China (2005) Chinese Pharmacopoeia, 528
38. Liu, A. H., Lin, Y. H., Yang, M., Sun, J. H., Guo, H., and Guo, D. A. (2006) High-performance liquid chromatographic determination of tanshinones in the roots of Salvia miltiorrhiza and related traditional Chinese medicinal preparations. J. Pharm. Pharm. Sci. 9, 1-9